Resources

Choosing a digital pathology platform for your lab involves many considerations. This framework focuses on one important aspect: how well a platform supports AI applications. It outlines seven criteria for pathologists, lab directors, and IT stakeholders to consider, along with practical questions to ask vendors during an evaluation.

Proscia is being acquired by Agilent Technologies. Nathan Buchbinder, Coleman Stavish, and I started Proscia in our college dorm rooms with a big vision to rewire pathology for precision medicine and help change the way we fight diseases like cancer. Proscia has always been a long-term play – what would medicine look like in the next 50 years? 10 years after our founding, joining Agilent opens an exciting next chapter to accelerate our mission.

Concentriq provides Unilabs with a shared environment for connecting its pathologists, standardizing workflows, and centralizing AI. Pathologists can then share cases in a few clicks, bring in colleagues for second opinions regardless of location, and collaborate virtually—all while supporting diagnostic consistency. Cases can also be routed among sites, helping Unilabs balance workloads across the network.

As laboratories scale digital pathology, interoperability gives them the freedom to add sites, connect systems, adopt new AI applications, and pursue growth without rebuilding their workflows. Ashley Faber explores why true openness must extend beyond a vendor’s claims and how Concentriq supports flexibility through integrations designed around pathologists’ day-to-day work, a commitment to DICOM, a broad precision medicine AI portfolio, and the Predetermined Change Control Plan authorized in Proscia’s latest FDA clearance for Concentriq AP-Dx.

Data science and AI teams at life sciences organizations do not lack promising ideas, or the expertise to translate them into strong AI capabilities. However, translating those AI investments into measurable impact is often hindered by the complex, production-grade infrastructure required to put models to work reliably at scale. Learn how Concentriq helps life sciences organizations easily deploy and scale their internally developed pathology AI models without building and maintaining the infrastructure around them.

When evaluating an enterprise pathology platform, many life sciences organizations and diagnostic laboratories focus on the features it offers. This makes sense since scientists and pathologists will rely on that functionality every day. We recently sat down with Kary to discuss his background, support philosophy, and initial priorities. Read the Q&A.

Concentriq will serve as the foundation for the work, with Proscia’s Aperture network providing a path for additional collaboration with drug developers, including 16 of the top 20 pharmaceutical companies.

SANTA CLARA, Calif. and PHILADELPHIA – October 13, 2026 – Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones.

Unilabs’ pathology network includes more than 350 experts and 400 laboratory technicians across 12 countries and analyzes 9 million sections each year. Concentriq brings together these teams, laboratory sites, diagnostic data, and AI capabilities in a single enterprise environment. Rather than confining expertise to an individual location, Concentriq gives hospitals and healthcare institutions easy access to the broader Unilabs network.

Lab leaders can see the potential of AI to expand capacity, improve consistency, and speed up turnaround time. Turning it into routine practice is the hard part. Hear how leaders from PathGroup and P&C Labs, who are actively running AI on Concentriq, built the business case and scaled it across their teams.

Diagnostic labs and drug development programs are under more pressure than ever — and a pathology platform with AI bolted on can't keep up. See the first official demo of Concentriq Fifth Generation, built with an enterprise AI layer at its core. Hear directly from customers optimizing clinical diagnostic workflows and advancing drug development research.

See how the platform works in practice across academic medical centers, health systems, and reference labs. Guest speaker Daniel Roberts, MD, Medical Director of Digital Pathology at Cleveland Clinic, shares what digital pathology adoption and change management actually looks like at one of the nation's largest academic medical centers.

AWS and Proscia Enterprise Digital Pathology Data Management‍: How Leading AP Labs Scale Digitization While Controlling Costs and Building an AI-Ready Foundation

Discover how to build a clear project vision, prepare your workflows for LIS integration, and empower pathologist champions to guide the transition to digital with ECPC, LigoLab and Proscia.